Shots: The companies collaborated to explore developing PDTs for the treatment of patients with selected indications within the gastrointestinal space The focus of the agreement is to merge Pear’s expertise […]readmore
Tags : Ironwood
Shots: Ironwood to receive three non-contingent payment of $35M b/w 2021 & 2024, ~$90M as a milestone with royalties on sales of Linzess in China mainland, China Hong Kong and […]readmore
Shots: The P-IIIb study results involve assessing of Inzess (290 mcg, qd) vs PBO in 614 adult patients on multiple abdominal symptoms with IBS-C The P-III study results met its […]readmore
Shots: As per Ironwood Zurampic generated $1.1Mn in 2Q18 and $3.1 Mn in 2017, company to reduce 125 field sales employees This termination agreement is expected to save $75-$100Mn […]readmore